Cancer cells use PARP1 to initiate a variety of DNA repair pathways, particularly BER and HR, to prevent cell death caused by the accumulation of cytotoxic DNA damage, making it a good candidate for sensitizing cancer cells to the cytotoxic effects of DNA damaging agents [101,102,103]. This evidence concerns the gene PARP1 and cancer.